It is a chemicals public limited company based in Nashik, Maharashtra, India, established in 2009.
2009 | Nashik, Maharashtra, India | Struck OffSoham Drugs And Intermediates Limited, a struck off public limited company, was established on 22 May 2009 in Nashik, Maharashtra, India. Engaging in fine chemicals and other chemical products within the chemicals sector, it holds CIN: U24299MH2009PLC192576. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹8.05 M.
Its leadership includes Seema Ramniwas Gupta (Director), Abha Tushar Gagrani (Director), Shailesh Sharad Kulkarni (Director). Past directors included Dilip Kachardas Sanklecha. Its latest AGM occurred on 24 September 2012, with the balance sheet filed on 31 March 2012. It is based at 21,Dehbanoo Complex ,Datta Mandir Square, Nashik Road ,Nashik, Nashik, Maharashtra, 422101.
U24299MH2009PLC192576
192576
22 May 2009
₹1.00 Cr
₹8.05 M
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Soham Drugs And Intermediates Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Seema Ramniwas Gupta | Director | 22 May 2009 | Current |
| Abha Tushar Gagrani | Director | 27 May 2009 | Current |
| Shailesh Sharad Kulkarni | Director | 22 May 2009 | Current |
| Soham Tushar Gagrani | Director | 22 May 2009 | Current |
| Tushar Hiralal Gagrani | Director | 27 May 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jan 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Soham Drugs And Intermediates's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Soham Drugs And Intermediates's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Soham Drugs And Intermediates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Soham Drugs And Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Soham Drugs And Intermediates's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Soham Drugs And Intermediates Limited last Annual general meeting of members was held on 24 Sep 2012 as per latest MCA records. was recorded as a recent event.
Soham Drugs And Intermediates Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Mumbai. was recorded as a recent event.
The activity Abha Tushar Gagrani was appointed as a Director was appointed as a Director on 27 May 2009 & has been associated with this company since 16 years 6 months . was completed.
The activity Tushar Hiralal Gagrani was appointed as a Director was appointed as a Director on 27 May 2009 & has been associated with this company since 16 years 6 months . was completed.
The activity Seema Ramniwas Gupta was appointed as a Director was appointed as a Director on 22 May 2009 & has been associated with this company since 16 years 6 months . was completed.
Progress on Shailesh Sharad Kulkarni was appointed as a Director was appointed as a Director on 22 May 2009 & has been associated with this company since 16 years 6 months . was documented.
The CIN of Soham Drugs And Intermediates Limited is U24299MH2009PLC192576.
Soham Drugs And Intermediates Limited is headquartered at 21,Dehbanoo Complex ,Datta Mandir Square, Nashik Road ,Nashik, Nashik, Maharashtra, 422101.
Soham Drugs And Intermediates Limited was incorporated on 22 May 2009.
The current directors of Soham Drugs And Intermediates Limited are
The primary industry of Soham Drugs And Intermediates Limited is Chemicals.
Soham Drugs And Intermediates Limited is unlisted.
The authorized capital of Soham Drugs And Intermediates Limited is ₹1.00 Cr, and the paid-up capital is ₹8.05 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX